States Restrict PE In Healthcare, CapitalRx’s New Platform, NYU Criticized for Super Bowl Blunder

ZorroRX Rundown (2/12/25)

Mental Health Ghost Networks, Medicare Advantage Coops, & 340B Virtue Theater

ZorroRX Rundown (2/10/25)

Cost of 340B To Payers, Humana Saves $11 Billion W/ Value Based Care, Alphabet Sells Reinsurance Venture

ZorroRX Rundown (2/10/25)

C-SNP Surges, Lilly Sales Rise 45%, UHC’s Phone Call W/ Surgeon Mid-Procedure

AI Bests MDs, Stopping Pharmacies From Closing & 340B Basics

ZorroRX Rundown (2/5/25)

More Vertical Integration, Microplastics In The Brain, And AI Outperforms Doctors

ZorroRX Roundup (2/4/25)

A Healthcare Excellence Agenda, Small Group Market Deteriorates, & Prior Auth in Medicare Advantage

ZorroRX Rundown (1/30/2025)

JPM Health System Rundown, Primary Care Shortage Worsens, Cancer Mortality Declines

ZorroRX Rundown (1/29/25)

‘25 RX Price Increases, Mental Health Ghost Networks, More Issues For Independent Pharmacies

ZorroRX Round Up (1/28/25)

Microbiome & Disease, Prime Therapeutics Antitrust Loss, and RPM Efficacy

ZorroRX Rundown (1/27/25)

PA Roadblocks, ADHD Life Expectancy, & Barriers To HIV Prevention/Treatment

ZorroRX Rundown (1/23/25)

Medicare Price Floor, Big 3 Are More Profitable, & Baby Formula Shortages

ZorroRX Round Up (1/22/24)